Splitable tip catheter with bioresorbable adhesive

Information

  • Patent Grant
  • 8992454
  • Patent Number
    8,992,454
  • Date Filed
    Wednesday, June 9, 2004
    20 years ago
  • Date Issued
    Tuesday, March 31, 2015
    9 years ago
Abstract
Splitable-tip catheters are disclosed with bioresorbable adhesive to provide spatial separation of distal tip elements during use. The invention can be particularly useful in hemodialysis applications where it is desirable to separate blood extraction and return lumens. The adhesive facilitates insertion of the distal end of the catheter as an assembly, e.g., into a blood vessel using a single guidewire, while the bioresorbable nature of the adhesive allows the tip elements to separate in vivo.
Description
FIELD OF THE INVENTION

The present invention generally relates to catheters and preferably to multi-lumen catheters used for vascular access.


BACKGROUND OF THE INVENTION

Multi-lumen catheters and, in particular split-tip catheters, are desirable for various treatment applications such as hemodialysis where fluid extraction and infusion occur simultaneously. Hemodialysis is the separation of metabolic waste products and water from the blood by diffusion through a semipermeable membrane. Typically, a hemodialysis unit is connected to a patient's body by a catheter. The catheter's distal end is placed in a blood vessel and its proximal end is connected to a hemodialysis unit.


During hemodialysis, a patient's blood flows through a double lumen catheter to the hemodialysis unit which provides filtration and controls the flow of blood. A double lumen catheter has two lumens that independently allow fluid extraction and return. For example, one lumen can be used for removing blood from a patient for processing in the hemodialysis machine and the other lumen can be used for subsequently returning the processed blood back to the patient's circulatory system.


Parameters that can be varied to achieve adequate hemodialysis include blood flow rate, dialysis solution flow rate, dialyzer competency, and temperature. Generally, raising the blood flow rate increases dialyzer clearance of small molecular weight solutes. Consequently, higher blood flow rates have been used to improve dialysis clearance efficiency. However, conditions such as access recirculation decrease clearance. Access recirculation is the recirculation of treated blood back into the hemodialysis unit causing inadequate dialysis. This problem effectively reduces blood flow rates thereby diminishing the efficiency of the hemodialysis process causing the duration of the treatment needed for dialysis to increase. Access recirculation can be particularly of concern when using a double lumen catheter due to the close proximity of the intake and outflow ports at the distal tip of the catheter.


Various double lumen catheter designs have been suggested for the purpose of reducing access recirculation. The distal ends of intake and outflow lumens have been longitudinally spaced 20-30 mm apart to prevent recirculation. For example, Twardowski et al. U.S. Pat. No. 5,569,182 discloses that the lumen for return of blood back into the vein should terminate beyond the extraction lumen. The purpose of this is to prevent cleansed blood, exiting from the outlet point of the catheter, from re-entering the catheter's blood inlet point and returning to the dialysis machine. However, certain disadvantages have been noted by such large longitudinal spacing between the distal ends of the respective lumens. For example, blood flow stagnation in the region of the blood vessel between two widely separated tips can lead to clot formation.


In addition to longitudinal spacing of the distal openings of the lumens for blood extraction and return, others have suggested that the distal end of a multi-lumen catheter can be split such that the distal tips of the lumens can independently move in the blood vessel to optimize the fluid dynamics of the different functions (blood extraction and blood return).


In general, good catheter outcomes depend on proper positioning of the catheter in the blood vessel. Insertion complications include pneumothorax, hemothorax, and cardiac tamponade, as well as poor blood flow rates, poor clearances, and long-term complications such as catheter dysfunction and fibrin sheath formation. These complications are compounded by the use of double lumen catheters because of their size.


Additional difficulties can be encountered when split distal tips must be inserted into a blood vessel. Typical insertion techniques of conventional double lumen catheters require the use of a peel-away sheath over a guidewire. Frequently there is a preference to insert the catheters without the use of a peel-away sheath to eliminate the risk of an air embolism by the use of two guidewires, or alternatively, inserting the guidewire through the one lumen and threading it through the side hole channels of the other lumen thus utilizing one guidewire, referred to as the “weave technique”. Moreover, precise positioning of a multi-lumen catheter can be challenging because the exact placement of the tips can not be assured. An improperly positioned multi-lumen catheter can further result in sub-optimal functionality requiring intervention.


Thus, there remains a need for a multi-lumen catheter that addresses the problems of access recirculation yet retains the comparative ease of insertion of a single lumen catheter.


SUMMARY OF THE INVENTION

Splitable-tip catheters are disclosed having tip elements that are joined with biodegradable or biosoluble adhesive to facilitate insertion and yet provide spatial separation of distal tip elements during use. The invention can be particularly useful in hemodialysis applications where it is desirable to separate blood extraction and return lumens. The adhesive facilitates insertion of the distal end of the catheter as an assembly, e.g., into a blood vessel using a single guidewire, while the biodegradable or biosoluble nature of the adhesive allows the tip elements to separate in vivo. The term “bioresorbable” as used herein encompasses both biodegradable and biosoluble materials.


The biodegradable adhesive, applied to the contacting surfaces of the distal tips of the extraction and return lumens, can be formed from various polymer or copolymer compositions. Additionally, the adhesive can be composed such that the time in which the adhesive biodegrades or biodisolves can be in the range of about 1 second to 1 hour. More generally, the adhesives of the present invention can bio-resorb from about 1 second to about 7 days, or from about 1 second to about 1 day, or from about 1 second to about 1 hour, or from about 1 second to about 10 minutes, or from about 10 seconds to about 5 minutes. In another embodiment a splitable tip catheter is disclosed having distal fluid openings to accelerate dissolution. The biodegradable or biosoluble adhesive can be water soluble such that the introduction of saline or similar type fluid will dissolve the adhesive and facilitate the separation of the distal tip elements.


An embodiment of the present invention provides a multi-lumen catheter device for hemodialysis having an elongate catheter body with at least one blood extraction lumen and one blood return lumen extending longitudinally therethrough. The proximal end of the instrument can be adapted for coupling to a hemodialysis apparatus and the distal end terminates in separable distal tip portions adapted for insertion into a blood vessel. The distal end of the catheter includes a distal extraction tip portion for fluid coupling of the extraction lumen with the blood vessel and a distal return tip portion for fluid coupling of the return lumen with the blood vessel, such that biodegradable or biosoluble adhesive joins the distal tip portions together prior to insertion into the blood vessel and facilitates the separation of the distal tip portions from each other following insertion.


Another embodiment of the present invention provides a method for hemodialysis to include providing a multi-lumen catheter assembly with at least a blood extraction lumen and a blood return lumen extending longitudinally therethrough, each lumen having a proximal end adapted for coupling to a hemodialysis apparatus and a distal end terminating in separable distal tip portions for blood extraction and return where the tip portions are joined together by a biodegradable or biosoluble adhesive. The method further provides for inserting the distal end of the catheter assembly into a blood vessel and allowing the adhesive to degrade such that the distal tip portions separate from each other within the blood vessel.


Therefore, the present invention addresses current problems associated with conventional split-tip catheter insertion by joining the distal tips of a split-tip catheter with biodegradable or biosoluble adhesive. After insertion of the catheter into the patient, the biodegradable or biosoluble adhesive dissolves and the distal tips of the split-tip catheter are free to move and function like conventional split-tip, double lumen, triple lumen, or multi-lumen catheters.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:



FIG. 1A is a schematic, perspective view of an embodiment of the present invention showing distal tip portions joined together;



FIG. 1B is a schematic, perspective view of an embodiment of the present invention showing distal tip portions separated from one another;



FIG. 1C is a schematic view of an embodiment of the present invention in use in the body of a patient;



FIG. 2A is a cross-section view of an embodiment of the present invention showing opposed “D” shaped lumens inside an outer sheath;



FIG. 2B is a cross-section view of an embodiment of the present invention showing unibody construction utilizing opposed “D” shaped lumens;



FIG. 2C is a cross-section view of an embodiment of the present invention showing yet another unibody construction;



FIG. 2D is a cross-section view of an embodiment of the present invention showing individual lumens inside an outer sheath;



FIG. 2E is a cross-section view of an embodiment of the present invention showing a unibody construction utilizing individual lumens;



FIG. 2F is a cross-section view of a variation of an embodiment of the present invention showing opposed “D” shaped lumens;



FIG. 2G is a cross-section view of an embodiment of the present invention showing three lumens;



FIG. 2H is a cross-section view of a variation of an embodiment of the present invention showing three lumens;



FIG. 2I is a cross-section view of a yet another variation of an embodiment of the present invention showing three lumens;



FIG. 3A is a schematic, perspective view of an embodiment of the present invention showing an adhesive application using spots of adhesive;



FIG. 3B is a schematic, perspective view of an embodiment of the present invention showing an adhesive application using regions of adhesive;



FIG. 4A is a cross-section view near the distal end of a catheter according to the present invention showing distal tip portions adhered to one another;



FIG. 4B is an distal cross-sectional view of another embodiment of the present invention showing alternative adhesive disposition;



FIG. 4C is a distal cross-sectional view of yet another adhesive design;



FIG. 5A is a schematic, perspective view of another embodiment of the present invention showing distal tip portions joined and wound about one another;



FIG. 5B is a schematic, perspective view of the embodiment of FIG. 5A with the distal tip portions shown in a separated state;



FIG. 5C is a schematic, perspective view of an embodiment of the present invention showing one lumen wound about another lumen;



FIG. 6A is a schematic, perspective view of an embodiment of the present invention showing fluid openings in the distal tip portions;



FIG. 6B is a schematic, perspective view of an embodiment of the present invention showing a design having an additional center lumen;



FIG. 6C is a cross-sectional view of an embodiment of the present invention showing a design having an additional center lumen;



FIG. 7A is a schematic, perspective view of an embodiment of the present invention showing distal tip portions adhered to one another in a shape memory configuration;



FIG. 7B is a schematic, perspective view of the embodiment in FIG. 7A showing distal tip portions that are separated; and



FIG. 8 is schematic, perspective view of an embodiment of the present invention showing distal tip portions in an alternate shape memory configuration.





DETAILED DESCRIPTION OF THE INVENTION

As used herein, the term “bioresorbable” refers to materials that are biodegradable or biosoluble such that they degrade or break down by mechanical degradation upon interaction with a physiological environment into components that are metabolizable or excretable over a period of time.


The present invention includes various embodiments of a multi-lumen catheter for hemodialysis and methods of use. As shown in FIGS. 1A and 1B, one embodiment of catheter 10 includes an elongate body 20 having proximal and distal end 11 and 12, and at least one blood extraction lumen 30 and at least one blood return lumen 40 extending longitudinally therethrough. Each lumen 30, 40 has a proximal end 30′, 40′ adapted to direct fluid to, or couple directly with, a hemodialysis apparatus (not shown), and a distal end 31, 41 for insertion into a blood vessel. Distal extraction and return tip portions 32, 42 of each lumen 30, 40 include a distal end opening 33, 43 formed therein to provide for simultaneous flow of blood in opposite directions during hemodialysis. The distal extraction and return tip portions 32, 42 are joined by bioresorbable adhesive 90 prior to being inserted into a blood vessel such that after insertion, the bioresorbable adhesive degrades sufficiently to allow the distal extraction and return tip portions of each lumen 30, 40 to separate from one another.



FIGS. 1A and 1B illustrate an outer sheath 50 which covers and encloses the lumens 30, 40. The outer sheath 50 can be any shape and size and can be made of the same material as the lumens 30, 40 or other material compatible with insertion into a blood vessel. As illustrated in the embodiment shown in FIGS. 1A and 1B, the outer sheath 50 terminates proximal to the distal ends 31, 41 of the lumens 30, 40 such that the distal extraction and return tip portions 32, 42 of each lumen can separate from one another after being inserted into a blood vessel. FIG. 2A shows a cross-section 2-2 of one embodiment of an outer sheath 50. The outer sheath 50 can be any thickness and can have varying inner and outer shapes as well as varying inner and outer dimensions.



FIG. 2B illustrates another embodiment showing a cross-section of an elongate body 20 having unibody construction 500 which incorporates the blood extraction and blood return lumens 308, 408 in a single elongate body 20. The unibody catheter can be constructed such that sheath material 500′ separates the lumens 308, 408. The amount of sheath material around each lumen 308, 408 and in-between each lumen can vary but preferably allows for blood extraction and blood return in accordance with hemodialysis. Separating the sheath material in-between both lumens 308, 408 along a vertical axis y at one end of the unibody construction can separate the lumens from one another into distinct distal portions. A variety of methods known to one skilled in the art can be used to separate the material such as for example cutting or scoring.


In another embodiment of the present invention the elongate body 20 can be formed such that the blood extraction and blood return lumens 30 and 40 (or 300 and 400) are non-circular to increase the areas of their outer surfaces 350, 450 that are in contact as shown, for example, in cross-section in FIGS. 4A and 6C. As shown in FIGS. 3A and 3B, the facing surfaces can be joined by spots 91 as well as regions 94 of adhesive (further described below). The configuration of the lumens in this embodiment allows the lumens, as joined, to resemble a single, circular lumen prior to insertion. After insertion of the distal extraction and return tip portions (e.g., tip portions 32 and 42 or tip portions 325 and 425), into a blood vessel, the bioresorbable adhesive 90 can dissolve allowing the tip portions to separate and facilitate hemodialysis.


The lumens 30, 40 can have a variety of cross-sectional shapes and sizes but preferably, as shown in the embodiments in FIGS. 1B, 2A, 2B, 2F, 3A, 3B, 4A, 4C, 6B, 6C, 7A, and 7B, the lumens are “D” shaped. Alternately, each of the lumens 30, 40 can have a cross-sectional shape, size, or area that can be distinct from the other, as shown, for example, in FIGS. 2C, 2G, and 2H. FIG. 2A is a cross-section view of an embodiment of the present invention showing opposed “D” shaped lumens inside an outer sheath. FIG. 2B is a cross-section view of an embodiment of the present invention showing unibody construction utilizing opposed “D” shaped lumens. FIG. 2C is a cross-section view of an embodiment of the present invention showing yet another unibody construction. FIG. 2D is a cross-section view of an embodiment of the present invention showing individual lumens inside an outer sheath. FIG. 2E is a cross-section view of an embodiment of the present invention showing a unibody construction utilizing individual lumens. FIG. 2F is a cross-section view of a variation of an embodiment of the present invention showing opposed “D” shaped lumens. FIG. 2G is a cross-section view of an embodiment of the present invention showing three lumens. FIG. 2H is a cross-section view of a variation of an embodiment of the present invention showing three lumens. FIG. 2I is a cross-section view of a yet another variation of an embodiment of the present invention showing three lumens. The lumens 30, 40 can be made of any material consistent with materials presently known for catheters including any material which allows the distal tip portions 32, 42 of the lumens to be flexible and facilitate hemodialysis.


The distal extraction and return tip portions 32, 42 of each lumen 30, 40 include distal end openings 33, 43 formed thereon for the extraction or return of blood or other bodily fluids. The openings are preferably sized to allow the carrying of blood to and from the hemodialysis unit. The distal extraction and return tip portions 32, 42 can be the same length or, as shown in FIGS. 1A and 1B, can be different lengths. As shown, the distal extraction tip portion 32 of the blood extraction lumen 30 terminates proximal to the distal return tip portion 42 of the blood return lumen 40. However, in another embodiment, the distal return tip portion 42 of the blood return lumen 40 can terminate proximal to the distal extraction tip portion 32 of the blood extraction lumen 30. The longitudinal distance d between the distal extraction and return tip portions 32, 42 of each lumen 30, 40 can vary but preferably allows for performing blood extraction and blood return in accordance with hemodialysis. Prior to the distal end 11 of the catheter being inserted into a blood vessel, the distal extraction and return tip portions 32, 42 of the lumens 30, 40 are joined to one another with bioresorbable adhesive 90. After insertion into the blood vessel, bioresorbable adhesive 90 facilitates the separation of the distal extraction and return tip portions 32, 42 of the lumens 30, 40. The bioresorbable adhesive may degrade in blood in a desired time period, such as, for example, about 1 second to about 7 days, about 1 second to about 1 day, or about 1 second to about 1 hour.


The bioresorbable adhesive 90 used to join the distal extraction and return tip portions, 32, 42 of the lumens 30, 40 to one another can be a composition selected from the group of polymers consisting of polylactides, polyglycolides, polylactones, polyorthoesters, polyanhydrides, and copolymers and combinations thereof. In general, bioresorbable adhesives have bonding elements and degradable elements. The degradable elements can have the components of polylactide, polyglycolide and polylactones (polycaprolactone). The bonding elements can have hydrogen bonding strength (polyvinyl alcohol, polysaccharides) or can be able to polymerize as a single component (cyanoacrylates) or as two componets (epoxy compound plus amino compounds, or radical (light) initiators of acrylate compounds).


Proteins, sugars, and starch can also be used as an adhesive. By way of non-limiting example, antithrombotic agents such as heparin and hirudin, citrate, antithrombin-heparin complex, and albumin heparin complex as well as anti-infective agents such as chlorohexidine, silver, antibiotics, and antiseptic agents may be added to the adhesive.


In an embodiment of the present invention, polymers which can be useful include polyurethane, generally described as a copolymer of polyethylene glycol with polylactide or polyglycolide end capped with methacrylates. Another embodiment can include a two component composition, one component preferably including a low molecular weight polyurethane end capped with methacrylates, and the other component preferably including polylactide, polyglycolide, or polycaprolactone end capped with methacrylate.


In another embodiment of the present invention, one or more components can be used from styrene, methyl methacrylate, methyl acrylate, ethylene dimethacrylate, ethylene diacrylate, acrylamide, diurethane dimethacrylate, polyisoprenegraft-maleic acid monomethyl ester, azobis(cyanovaleric acid), azobiscyclohexanecarbonitrile, azobisisobutyronitrile, benzoyl peroxide, iron(II) sulfate, polyvinyl alcohol, dextran, polysaccharide, epichlorohydrin, ethylenediamine, diaminocyclohexane, diamino propane, copolymers with polylactide and polyethylene oxide as the blocks and acrylate, methacrylate as the end groups, cyanoacrylates, ethyl-2cyanoacrylate, propyl-2-cyanoacrylates, pentyl-2-cyanoacrylate, hexyl-2-cyanoacrylate, and octyl-2-cyanoacrylate, ammonium persulfate and/or polyethylene glycol methacrylate when water, organic solvent such as dichloromethane, chloroform, tetrahydrofuran, acetone, petroleum ether, acetyl acetate, dimethylformamide, or the mixture thereof, is combined with the aforementioned solvents.


As shown in FIGS. 1A, 3A, and 3B, bioresorbable adhesive can be applied along a facing surface 35, 45 of either, or both, distal extraction and return tip portions 32, 42 of the lumens 30, 40 to facilitate the joining of the lumens along their longitudinal length l prior to insertion of the distal end 11 of the catheter 10 into a blood vessel. (As used throughout, “catheter 10” refers to the various embodiments of the present invention.) FIG. 1A shows bioresorbable adhesive 90 applied along a longitudinal length l of the distal extraction and return tip portions 32, 42 of each lumen 30, 40. However, the bioresorbable adhesive 90 need not be applied along the entire length l of the facing surfaces 35, 45 of each lumen 30, 40 but is preferably applied such that the adhesive facilitates the joining of the distal extraction and return tip portions 32, 42 of the lumens 30, 40 prior to insertion into a blood vessel and allows the distal extraction and return tip portions of the lumens to separate after insertion.


In the embodiments described herein, the bioresorbable adhesive 90 preferably dissolves after insertion into a blood vessel to provide separation of the distal extraction and return tip portions 32, 42 of the lumens 30, 40 in a time period ranging from 1 minute to 1 hour. This range can be controlled by using different compositions of the bioresorbable adhesive 90 as well as by the amount of adhesive applied to join the distal extraction and return tip portions 32, 42 of the lumens 30, 40 together. In another embodiment with opposed distal fluid openings 80 (further described below), the bioresorbable adhesive 90 can be water soluble such that the introduction of saline or similar type fluid will effectuate the separation of the distal extraction and return tip portions 32, 42 of the lumens 30, 40. In this instance, the adhesive will not dissolve until a time after the introduction of the soluble solution into the lumens 30, 40.


As shown in another embodiment in FIG. 3A, the bioresorbable adhesive can also be applied to the facing surfaces of the distal extraction and return tip portions 32, 42 of the lumens 30, 40 in form as discrete spots 91. The spots 91 of bioresorbable adhesive 90 can be applied continuously along the entire longitudinal length l of the distal extraction and return tip portions 32, 42 of the lumens 30, 40 or selectively in an assortment of areas thereof. Preferably, the bioresorbable adhesive 90 is applied such that the spots 91 of adhesive facilitate the joining of the distal extraction and return tip portions 32, 42 of the lumens 30, 40 prior to insertion into a blood vessel and allow the distal extraction and return tip portions of the lumens to separate after insertion. The spots 91 of bioresorbable adhesive 90 can vary in number and size in order to facilitate the joining of the tip portions of the lumens.



FIG. 3B shows yet another embodiment of the application of the bioresorbable adhesive 90 in the form of discrete regions 94. Discrete regions 94, like the spots 91 stated above, of bioresorbable adhesive 90 can be applied to the facing surfaces of the distal extraction and return tip portions 32, 42 of the lumens 30, 40. The discrete regions 94 of bioresorbable adhesive 90 can also be different lengths and can be applied in addition to discrete spots 91 of adhesive such that the adhesive facilitates the joining of the distal extraction and return tip portions 32, 42 of the lumens 30, 40 prior to insertion into a blood vessel and allows the distal extraction and return tip portions of the lumens to separate after insertion.



FIGS. 4A-4C show cross-sections of the distal extraction and return tip portions 32, 42 of the lumens 30, 40 detailing alternate embodiments of the bioresorbable adhesive 90 application. FIG. 4A shows bioresorbable adhesive 90 applied at the contact point 70 of the facing surfaces 35, 45 of the lumens 30, 40. FIG. 4B shows another embodiment of an application of the bioresorbable adhesive 90 such that the adhesive, as applied, joins non-contacting surfaces 36, 46 of the distal extraction and return tip portions 32, 42 of the lumens 30, 40. FIG. 4C shows a variation on the embodiment shown in FIG. 4A where the bioresorbable adhesive 90 surrounds the distal extraction and return tip portions 32, 42 of the lumens 30, 40 forming a continuous cross-section of adhesive coating notwithstanding the distal extraction and return tip portions of the lumens extending therethrough. As stated above, the bioresorbable adhesive 90 need not be applied along the entire length of the distal extraction and return tip portions 32, 42 of each lumen 30, 40 but is preferably applied such that the adhesive facilitates the joining of the distal extraction and return tip portions of the blood extraction and blood return lumens prior to insertion into a blood vessel and allows the distal extraction and return tip portions of the lumens to separate after insertion. It should be noted that because the lumens 30, 40 can be various shapes, as stated above, the bioresorbable adhesive 90 need not be applied to all of the contact area along length l of the facing surfaces 35, 45 of each lumen 30, 40, as shown in FIG. 1A. As shown in FIGS. 3A and 3B, the bioresorbable adhesive 90 can be applied as a region 94, spot 91, or other shape, to a section of the contact area and need only be applied to facilitate the joining function.



FIG. 5A illustrates another embodiment of the present invention. As shown, the lumens 30, 40 are twisted about, or otherwise wrapped, around one another. The wrapped lumens can be twisted about one another such that there are non-contact areas, along the longitudinal length l of the distal extraction and return tip portions of each lumen 30, 40 as shown in FIG. 5A. In FIG. 5B, the distal tip elements are shown in a separated state. The distal extraction and return tip portions of each lumen 30, 40 can wrap around one another any number of times, as well as wrap such that one lumen 30 is wound around the other lumen 40 as shown in FIG. 5C, or vice versa. In FIG. 5A, bioresorbable adhesive 90 can be applied where the distal extraction and return tip portions of the lumens 30, 40 contact one another. As stated above, the bioresorbable adhesive 90 can be applied in discrete spots or regions where the distal extraction and return tip portion surfaces contact one another. However, the bioresorbable adhesive need not be applied to all contact points of the twisted lumens 30, 40 so long as the joining of the distal extraction and return tip portions of the lumens 30, 40 can be facilitated. The various compositions and methods of application of the bioresorbable adhesive 90 application previously described above can also be used with the twisted embodiment catheter design as well.


In another embodiment of the present invention, FIG. 6A shows distal fluid openings 80, in formed in the distal extraction tip portion 32 of lumen 30. It should be understood from the drawings that in the embodiment shown, the distal fluid openings 80 can either be in addition to, or in place of, the distal end opening 33 located on the distal extraction tip portion 32 of lumen 30. The distal fluid openings 80 can be any shape and size and can be located in a variety of places on lumen 30 as illustrated. However, FIG. 6A shows the distal fluid openings 80 located on facing (contacting) surface 35 of the distal extraction tip portion 32 of lumen 30. In this embodiment, the distal fluid openings 80 can be filled or covered with fluid activated bioresorbable adhesive 900 and joined to lumen 40 along its facing surface 45. After insertion of the catheter into a blood vessel, saline or similar type fluid can be introduced into lumen 30 at its proximal end 30′ such that the fluid travels through the lumen to the distal fluid openings 80 and dissolves the fluid activated bioresorbable adhesive 900 thereby separating the distal extraction and return tip portions 32, 42 along their longitudinal length l to facilitate hemodialysis. Bioresorbable adhesive 90 can also be applied to the contact surfaces 35, 45 of each lumen as previously described above in addition to the distal fluid openings 80 being filled or covered with fluid activated bioresorbable adhesive 900.



FIG. 6B shows yet another embodiment in which the catheter 10 can be designed to facilitate separation of its distal tips 325, 425 after insertion into a blood vessel. Catheter 10 can include a center lumen 60 extending in-between lumens 300, 400 from a proximal end 120 to a separation point 62 and can be used to carry saline or a similar type fluid. At the separation point 62, the center lumen splits into two center lumen halves 63′, 64′ each half located in a facing surface 350, 450 of each lumen 300, 400. The center lumen 60 can be made f a variety of cross-sectional shapes but is preferably circular. As shown, the center lumen halves 63′, 64′ terminate proximal to the distal ends 310, 410 of lumens 300, 400. It should be noted that a mirrored portion of center lumen half 64′ is located in the facing surface 450 of distal return tip 425. The proximal end of center lumen 60, which is out of view in FIG. 6B, can extend at the proximal end 120 of catheter 10 anywhere outside the patient so long as the center lumen 60 can be accessible for saline fluid introduction. As shown in FIG. 6C, the center lumen 60 and the center lumen halves 63′, 64′ are not in fluid communication with either of the lumens 300, 400. Distal extraction and return tip portions 325, 425 can have fluid activated bioresorbable adhesive 900 applied anywhere within center lumen halves 63′, 64′ distal of a center lumen gap. The adhesive 900 can also be applied at or beyond a center lumen half end, to facilitate separation of the distal tip portions 325, 425. The center lumen gap, of any desirable length, should remain free of fluid activated bioresorbable adhesive 900 and in fluid communication with a blood vessel in order to allow any extraneous saline or similar type fluid to be displaced between the facing surfaces 350, 450 and into the bloodstream during the dissolving process.


In this embodiment, the catheter 10 is inserted into a patient and saline or other type fluid can be introduced into the center lumen 60 at its proximal end which dissolves the fluid activated bioresorbable adhesive 900 applied at or beyond center lumen gap. Once separated, the distal tip portions 325, 425 can facilitate blood extraction and blood return in accordance with hemodialysis through distal end openings of lumena 300, 400.


In FIGS. 7A and 7B, another embodiment of the present invention is shown in which one or both of the lumens 30, 40 can be made of a shape memory material such that after insertion of the distal end 11 of the device into a blood vessel, and upon the bioresorbable adhesive 90 dissolving, the lumens, and more preferably the distal extraction and return tip portions 32, 42 thereof, can separate to a pre-adhesive position. The distal extraction and return tip portions 32, 42 of the lumens 30, 40 can be made of polymer material or other material as needed or combined to facilitate the shape memory in the described embodiment. FIGS. 7A and 7B illustrate the lumens 30, 40 in this configuration. The distal extraction and return tip portions 32, 42 of each lumen 30, 40 are joined with bioresorbable adhesive 90 prior to insertion into a blood vessel. A memory gap 93 can be located between the lumens and distal of the outer sheath 50. The memory gap can be any length and width but preferably allows for a configuration such that the lumens 30, 40 are not pinched after joining. As shown, each lumen 30, 40 exits the outer sheath 50 in a non-parallel, diverging direction. The relative angle α at which the lumens 30, 40 exit the outer sheath 50 can vary. Bioresorbable adhesive 90 can be applied, in any manner described herein, to join the lumens 30, 40 distal of the memory gap 93. FIG. 7B shows the lumens 30, 40 in roughly a “pre-adhesive” configuration as well as in an “after insertion into a blood vessel” configuration. It should be noted that the lumens 30, 40 illustrated in FIG. 7B, can separate more or less, after being inserted into a blood vessel, as compared to their pre-adhesive state.


In another embodiment, the distal extraction and return tip portions 32, 42 of each of the lumens 30, 40 can be preformed to exit the outer sheath 50 in a substantially parallel direction and then angularly diverge from one another, at a location distal from the outer sheath, upon the degradation of the bioresorbable adhesive 90, as shown in FIG. 8. The distal extraction and return tip portions 32, 42 of each lumen 30, 40 shown in FIG. 8, exit the outer sheath 50 in a distal direction and are substantially parallel relative to one another. As the bioresorbable adhesive 90, applied in any manner described herein, dissolves, the distal extraction and return tip portions 32, 42 of the lumens 30, 40 substantially separate and angularly diverge from one another along a longitudinal axis b. Distal extraction and return tip portions 32, 42 of each lumen 30, 40 can be pre-formed from polymer or similar type polymer materials to effectuate this divergence. As further shown in FIG. 7, the distal extraction and return tip portions 32, 42 can re-converge toward each other if desired or can continue diverging as shown in FIG. 6B.


In use, a catheter 10 is provided having distal extraction and return tip portions 32, 42 which are joined to one another using any of the bioresorbable adhesive applications described throughout this specification. The proximal end 12 of the catheter 10 can be attached to a hemodialysis apparatus using various attachment means known to one skilled in the art. The distal end 11 of the catheter 10 can be inserted into a blood vessel wherein the bioresorbable adhesive 90 is allowed to dissolve in a time in the range of 1 minute to 1 hour, such that the distal extraction and return tip portions 32, 42 of the blood extraction lumen 30 and the blood return lumen 40 separate from each other within the blood vessel. Blood extraction and blood return can be subsequently commenced through each lumen 30, 40 according to hemodialysis methods and practices.


Accordingly, the embodiments of the present invention are not limited by what has been particularly shown and described, except as indicated by the appended claims. All publications and references cited herein are expressly incorporated herein by reference in their entirety.

Claims
  • 1. A multi-lumen catheter device for hemodialysis, comprising: an elongate catheter body with at least a blood extraction lumen and a blood return lumen extending longitudinally therethrough, having a proximal end adapted for coupling to a hemodialysis apparatus, and having a distal end terminating in separable distal tip portions adapted for insertion in a blood vessel, the distal end further comprising: a distal extraction tip portion for fluidic coupling of the extraction lumen with the blood vessel,a distal return tip portion for fluidic coupling of the return lumen with the blood vessel, anda cyanoacrylate-free bioresorbable adhesive, comprising a bonding element and a degradable element, located between the separable distal tip portions to join the distal tip portions together prior to insertion into a blood vessel, the bioresorbable adhesive enabling the distal tip portions to separate following insertion;wherein at least one distal tip portion is made of a shape memory material to facilitate an angular separation of the distal tip portions from each other to a pre-adhesive position following degradation of the adhesive.
  • 2. The device of claim 1, wherein the extraction and return lumens are independent of each other to provide simultaneous flow of blood in opposite directions during hemodialysis.
  • 3. The device of claim 1, wherein the adhesive comprises a hydrophilic polymer.
  • 4. The device of claim 1, wherein the adhesive comprises a water-soluble composition.
  • 5. The device of claim 1, wherein the adhesive degrades in blood in a time period ranging from about 1 second to about 7 days.
  • 6. The device of claim 1, wherein the adhesive degrades in blood in a time period ranging from about 1 second to about 1 day.
  • 7. The device of claim 1, wherein the adhesive degrades in blood in time period ranging from about 1 second to about 1 hour.
  • 8. The device of claim 1, wherein the adhesive comprises a composition selected from the group consisting of polylactides, polyglycolides, polylactones, polyorthoesters, polyanhydrides, and copolymers thereof.
  • 9. The device of claim 1, wherein the adhesive comprises a protein, a sugar, and a starch.
  • 10. The device of claim 1, wherein the adhesive comprises an antithrombotic, anti-septic, or anti-stenotic agent.
  • 11. The device of claim 1, wherein the extraction and return lumens have different cross-sectional areas.
  • 12. The device of claim 1, wherein the distal tip portions each have at least one opening for fluid flow, the fluid flow facilitating the dissolution of the adhesive and separation of the distal tip portions from each other following insertion.
  • 13. The device of claim 1, wherein at least one of the distal tip portions has a plurality of openings for fluid flow.
  • 14. The device of claim 1, wherein the elongate catheter body has unibody construction with the extraction lumen and the return lumen incorporated therein.
  • 15. The device of claim 1, wherein extraction and return lumens are separate tubular elements and partially joined by an outer sheath.
  • 16. The device of claim 1, wherein the adhesive covers at least a portion of an outer surface of each distal tip portion.
  • 17. The device of claim 1, wherein the adhesive is applied to a surface of each distal tip portion in a continuous linear bond.
  • 18. The device of claim 1, wherein the adhesive is applied to a surface of each distal tip portion at discrete regions.
  • 19. The device of claim 1, wherein at least one distal tip portion is coiled about another tip portion.
  • 20. The device of claim 1, wherein the catheter contains an additional lumen for fluid administration, the fluid administration facilitating the dissolution of the adhesive and separation of the distal tip portions from each other following insertion.
  • 21. The device of claim 20, wherein the additional lumen extends longitudinally between the blood extraction lumen and the blood return lumen, the additional lumen configured to direct fluid of the fluid administration at the adhesive between the separable distal tip portions to facilitate dissolution of the adhesive.
  • 22. A multi-lumen catheter device for hemodialysis, comprising: a proximal end adapted for coupling to a hemodialysis apparatus;a distal end terminating in a first distal tip portion and a second distal tip portion separably attached together with a cyanoacrylate-free bioresorbable adhesive comprising a bonding element and a degradable element, wherein dissolution of the bioresorbable adhesive following insertion of the distal end in a blood vessel enables the first distal tip portion and the second distal tip portion to separate;a first lumen for blood extraction extending longitudinally from the proximal end through the first distal tip portion;a second lumen for blood return extending longitudinally from the proximal end through the second distal tip portion; anda third lumen extending longitudinally in between the first lumen and the second lumen from the proximal end to a separation point between the first distal tip portion and the second distal tip portion, wherein the third lumen is designed such that fluid administered through the third lumen is directed from the third lumen at the bioresorbable adhesive between the first distal tip portion and the second distal tip portion to facilitate the dissolution of the bioresorbable adhesive and separation of the first distal tip portion and the second distal tip portion.
  • 23. The device of claim 22, wherein at least one of the first distal tip portion and the second distal tip portion is made of a shape memory material to facilitate an angular separation of the first distal tip portion and the second distal tip portion from each other to a pre-adhesive position following dissolution of the adhesive.
  • 24. The device of claim 22, wherein at the separation point the third lumen splits into a first lumen half located in a first surface of the first distal tip portion and a second lumen half located in a second surface of the second distal tip portion, wherein the first surface and the second surface face each other.
US Referenced Citations (623)
Number Name Date Kind
701075 McCully May 1902 A
1696018 Scheliberg Dec 1928 A
1856811 Inaki May 1932 A
2024982 Scott Dec 1935 A
2173527 Agayoff Sep 1939 A
2286462 Chaffin Jun 1942 A
2393002 Smith Jan 1946 A
2910981 Wilson et al. Nov 1959 A
3144868 Jascalevich Aug 1964 A
3176690 H'Doubler Apr 1965 A
3256885 Higgins et al. Jun 1966 A
3416532 Grossman Dec 1968 A
3426759 Smith Feb 1969 A
3460255 Hutson Aug 1969 A
D217795 Spaven Jun 1970 S
3612038 Halligan Oct 1971 A
3736939 Taylor Jun 1973 A
3805794 Schlesinger Apr 1974 A
3812851 Rodriguez May 1974 A
3848604 Sackner Nov 1974 A
3890977 Wilson Jun 1975 A
3929126 Corsaut Dec 1975 A
3935857 Co Feb 1976 A
3995623 Blake et al. Dec 1976 A
4068659 Moorehead Jan 1978 A
4072146 Howes Feb 1978 A
4072153 Swartz Feb 1978 A
4098275 Consalvo Jul 1978 A
4114625 Onat Sep 1978 A
4117836 Erikson et al. Oct 1978 A
4129129 Amrine Dec 1978 A
4134402 Mahurkar Jan 1979 A
4149535 Volder et al. Apr 1979 A
4180068 Jacobsen et al. Dec 1979 A
4248224 Jones Feb 1981 A
4276880 Malmin Jul 1981 A
4292976 Banka Oct 1981 A
4299228 Peters Nov 1981 A
4300550 Gandi et al. Nov 1981 A
4309994 Grunwald Jan 1982 A
4327722 Groshong et al. May 1982 A
4385631 Uthmann May 1983 A
4392855 Oreopoulos et al. Jul 1983 A
4403983 Edelman et al. Sep 1983 A
4405313 Sisley et al. Sep 1983 A
4406656 Hattler et al. Sep 1983 A
D272651 Mahurkar Feb 1984 S
4431426 Groshong et al. Feb 1984 A
4432722 Bohan, Jr. et al. Feb 1984 A
4432752 Marlon Feb 1984 A
4445893 Bodicky May 1984 A
4451252 Martin May 1984 A
4453928 Steiger Jun 1984 A
4465482 Tittel et al. Aug 1984 A
4490138 Lipsky et al. Dec 1984 A
4493696 Uldall Jan 1985 A
RE31873 Howes Apr 1985 E
4531933 Norton et al. Jul 1985 A
4543087 Sommercorn et al. Sep 1985 A
4545373 Christoudias Oct 1985 A
4549879 Groshong et al. Oct 1985 A
4557261 Rugheimer et al. Dec 1985 A
4568329 Mahurkar Feb 1986 A
4568338 Todd Feb 1986 A
4573476 Ruiz Mar 1986 A
4581012 Brown et al. Apr 1986 A
4583968 Mahurkar Apr 1986 A
4583986 Lapidus Apr 1986 A
4601697 Mammolenti et al. Jul 1986 A
4619643 Bai Oct 1986 A
4623327 Mahurkar Nov 1986 A
4626240 Edelman et al. Dec 1986 A
4642101 Krolikowski et al. Feb 1987 A
4643711 Bates Feb 1987 A
4666426 Aigner et al. May 1987 A
4668221 Luther May 1987 A
4670009 Bullock Jun 1987 A
4675004 Hadford et al. Jun 1987 A
4681122 Winters et al. Jul 1987 A
4681564 Landreneau Jul 1987 A
4681570 Dalton Jul 1987 A
4682978 Martin Jul 1987 A
4687471 Twardowski et al. Aug 1987 A
4692141 Mahurkar Sep 1987 A
4694838 Wijayarthna et al. Sep 1987 A
4701159 Brown et al. Oct 1987 A
4702917 Schindler Oct 1987 A
4713171 Polaschegg Dec 1987 A
4717379 Ekholmer et al. Jan 1988 A
4735620 Ruiz Apr 1988 A
4737141 Spits Apr 1988 A
4737152 Alchas Apr 1988 A
4738667 Galloway Apr 1988 A
4748808 Hill Jun 1988 A
4755176 Patel Jul 1988 A
4769016 Labianca et al. Sep 1988 A
4770652 Mahurkar Sep 1988 A
4772268 Bates Sep 1988 A
4772269 Twardowski et al. Sep 1988 A
4776841 Catalano Oct 1988 A
4777951 Cribier et al. Oct 1988 A
4784638 Ghajar et al. Nov 1988 A
4790809 Kuntz Dec 1988 A
4795439 Guest Jan 1989 A
4801297 Mueller Jan 1989 A
4804359 Grunwald et al. Feb 1989 A
4808155 Mahurkar Feb 1989 A
4808163 Laub Feb 1989 A
4809710 Williamson Mar 1989 A
4820265 DeSatnick et al. Apr 1989 A
4832687 Smith, III May 1989 A
4834709 Banning et al. May 1989 A
4842582 Mahurkar Jun 1989 A
4842592 Caggiani et al. Jun 1989 A
4846814 Ruiz Jul 1989 A
4863441 Lindsay et al. Sep 1989 A
4867742 Calderon Sep 1989 A
4892518 Cupp et al. Jan 1990 A
4894057 Howes Jan 1990 A
4895561 Mahurkar Jan 1990 A
4898591 Jang et al. Feb 1990 A
4906238 Greenfeld et al. Mar 1990 A
4925452 Melinyshyn et al. May 1990 A
4927418 Dake et al. May 1990 A
4935004 Cruz Jun 1990 A
4935010 Cox et al. Jun 1990 A
4935044 Schoenpflug et al. Jun 1990 A
4936826 Amarasinghe Jun 1990 A
4950232 Ruzicka et al. Aug 1990 A
4950259 Geary et al. Aug 1990 A
4951665 Schneider Aug 1990 A
4961729 Vaillancourt Oct 1990 A
4961731 Bodicky et al. Oct 1990 A
4961809 Martin et al. Oct 1990 A
4968307 Dake et al. Nov 1990 A
4969890 Sugita et al. Nov 1990 A
4981477 Schon et al. Jan 1991 A
4985014 Orejola Jan 1991 A
4990138 Bacich et al. Feb 1991 A
4994027 Farrell Feb 1991 A
4995865 Gahara et al. Feb 1991 A
5009636 Wortley et al. Apr 1991 A
5015230 Martin et al. May 1991 A
5016640 Ruiz May 1991 A
5021044 Sharkawy Jun 1991 A
5041101 Seder et al. Aug 1991 A
5041107 Heil, Jr. Aug 1991 A
5049138 Chevalier et al. Sep 1991 A
5053003 Dadson et al. Oct 1991 A
5053004 Markel et al. Oct 1991 A
5053023 Martin Oct 1991 A
5057073 Martin Oct 1991 A
5059170 Cameron Oct 1991 A
5069673 Shwab Dec 1991 A
5074841 Ademovic et al. Dec 1991 A
5084013 Takase et al. Jan 1992 A
5098412 Shiu Mar 1992 A
5100395 Rosenberg Mar 1992 A
5102402 Dror et al. Apr 1992 A
5106368 Uldall et al. Apr 1992 A
5106376 Mononen et al. Apr 1992 A
5111829 Alvarez de Toledo May 1992 A
5112301 Fenton, Jr. et al. May 1992 A
5114423 Kasprzyk et al. May 1992 A
5117836 Millar Jun 1992 A
5120299 Lombardi Jun 1992 A
5120304 Sasaki Jun 1992 A
5122125 Deuss et al. Jun 1992 A
5125904 Lee Jun 1992 A
5129891 Young Jul 1992 A
5135599 Martin et al. Aug 1992 A
5139486 Moss Aug 1992 A
5156592 Martin et al. Oct 1992 A
5163928 Hobbs et al. Nov 1992 A
5167623 Cianci et al. Dec 1992 A
5171216 Dasse et al. Dec 1992 A
5171227 Twardowski et al. Dec 1992 A
5178616 Uemiya et al. Jan 1993 A
5188592 Hakki Feb 1993 A
5188593 Martin Feb 1993 A
5190520 Fenton et al. Mar 1993 A
5190529 McCrory et al. Mar 1993 A
5191898 Millar Mar 1993 A
5195962 Martin et al. Mar 1993 A
5197951 Mahurkar Mar 1993 A
5197973 Pang et al. Mar 1993 A
5197976 Herweck et al. Mar 1993 A
5207648 Gross May 1993 A
5207650 Martin May 1993 A
5209723 Twardowski et al. May 1993 A
5209725 Roth May 1993 A
5209742 Venema et al. May 1993 A
5211256 Muramatsu et al. May 1993 A
5215527 Beck et al. Jun 1993 A
5221255 Mahurkar et al. Jun 1993 A
5221256 Mahurkar Jun 1993 A
5222949 Kaldany Jun 1993 A
5226880 Martin et al. Jul 1993 A
5234438 Semrad Aug 1993 A
5236016 Vogelsang et al. Aug 1993 A
5242398 Knoll et al. Sep 1993 A
5246430 MacFarlane Sep 1993 A
5250034 Appling et al. Oct 1993 A
5254084 Geary Oct 1993 A
5273527 Schatz et al. Dec 1993 A
5273534 Knoepfler Dec 1993 A
5279596 Castaneda et al. Jan 1994 A
5279599 Wilk Jan 1994 A
5306240 Berry Apr 1994 A
5312337 Flaherty et al. May 1994 A
5312357 Buijs et al. May 1994 A
5318517 Reiman Jun 1994 A
5322519 Ash Jun 1994 A
5324274 Martin Jun 1994 A
5338308 Wilk Aug 1994 A
5342295 Imran Aug 1994 A
5342386 Trotta Aug 1994 A
5346471 Raulerson Sep 1994 A
5348536 Young et al. Sep 1994 A
5350358 Martin Sep 1994 A
5360397 Pinchuk Nov 1994 A
5360407 Leonard et al. Nov 1994 A
5364344 Beattie et al. Nov 1994 A
5374245 Mahurkar Dec 1994 A
5378230 Mahurkar Jan 1995 A
5380276 Miller et al. Jan 1995 A
5380290 Makower et al. Jan 1995 A
5382238 Abrahamson et al. Jan 1995 A
5389087 Miraki Feb 1995 A
5389090 Fischell et al. Feb 1995 A
5395316 Martin et al. Mar 1995 A
5399168 Wadsworth, Jr. et al. Mar 1995 A
5403291 Abrahamson Apr 1995 A
5405320 Twardowski et al. Apr 1995 A
5405341 Martin Apr 1995 A
5409463 Thomas et al. Apr 1995 A
5417668 Setzer et al. May 1995 A
5423768 Folden et al. Jun 1995 A
5431661 Koch Jul 1995 A
5451026 Smith Sep 1995 A
5451206 Young Sep 1995 A
5451233 Yock Sep 1995 A
5458570 May, Jr. Oct 1995 A
5458582 Nakao Oct 1995 A
5472417 Martin et al. Dec 1995 A
5472432 Martin Dec 1995 A
5476453 Mehta Dec 1995 A
5480380 Martin Jan 1996 A
5486159 Mahurkar Jan 1996 A
5489278 Abrahamson Feb 1996 A
5496292 Burnham Mar 1996 A
5496872 Constancis et al. Mar 1996 A
5505710 Dorsey, III Apr 1996 A
5507723 Keshaviah Apr 1996 A
5509897 Twardowski et al. Apr 1996 A
5509900 Kirkman Apr 1996 A
5509902 Raulerson Apr 1996 A
5542925 Orth Aug 1996 A
5545373 Maziasz et al. Aug 1996 A
5556390 Hicks Sep 1996 A
5556930 Brehm et al. Sep 1996 A
5558635 Cannon Sep 1996 A
5562609 Brumbach Oct 1996 A
5569182 Twardowski et al. Oct 1996 A
5569195 Saab Oct 1996 A
5571093 Cruz et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5599304 Shaari Feb 1997 A
5599328 Stevens Feb 1997 A
5607462 Imran Mar 1997 A
5624392 Saab Apr 1997 A
5624413 Markel et al. Apr 1997 A
5632729 Cai et al. May 1997 A
5637102 Tolkoff et al. Jun 1997 A
5642270 Green et al. Jun 1997 A
5655867 Gysi et al. Aug 1997 A
5662606 Cimino et al. Sep 1997 A
5665067 Linder et al. Sep 1997 A
5685867 Twardowski et al. Nov 1997 A
5686867 Sutardja et al. Nov 1997 A
5693030 Lee et al. Dec 1997 A
5695457 St. Goar et al. Dec 1997 A
5704915 Melsky et al. Jan 1998 A
5713849 Bosma et al. Feb 1998 A
5713853 Clark et al. Feb 1998 A
5717216 McCoy et al. Feb 1998 A
5718678 Fleming, III Feb 1998 A
5718692 Schon et al. Feb 1998 A
5720735 Dorros Feb 1998 A
5738649 Macoviak Apr 1998 A
5741329 Agrawal et al. Apr 1998 A
5743873 Cai et al. Apr 1998 A
5752939 Makoto et al. May 1998 A
5769796 Palermo et al. Jun 1998 A
5772643 Howell et al. Jun 1998 A
5776096 Fields Jul 1998 A
5776111 Tesio Jul 1998 A
5785686 Runge Jul 1998 A
5792094 Stevens et al. Aug 1998 A
5792123 Ensminger Aug 1998 A
5797869 Martin et al. Aug 1998 A
5800384 Russell et al. Sep 1998 A
5800414 Cazal et al. Sep 1998 A
5800516 Fine et al. Sep 1998 A
5807311 Palestrant Sep 1998 A
5807318 St. Goar et al. Sep 1998 A
5807329 Gelman Sep 1998 A
5809897 Powell et al. Sep 1998 A
5810789 Powers et al. Sep 1998 A
5814016 Valley et al. Sep 1998 A
5830184 Basta Nov 1998 A
5830196 Hicks Nov 1998 A
5833671 Macoviak et al. Nov 1998 A
5858009 Jonkman Jan 1999 A
5861010 Boussignac et al. Jan 1999 A
5868717 Prosl Feb 1999 A
5873865 Horzewski et al. Feb 1999 A
5876366 Dykstra et al. Mar 1999 A
5876426 Kume et al. Mar 1999 A
5882347 Mouris-Laan et al. Mar 1999 A
5891111 Ismael et al. Apr 1999 A
5904670 Schreiner May 1999 A
5911715 Berg et al. Jun 1999 A
5913848 Luther et al. Jun 1999 A
5916208 Luther et al. Jun 1999 A
5919160 Sanfilippo, II Jul 1999 A
5944732 Raulerson et al. Aug 1999 A
5947937 Urrutia et al. Sep 1999 A
5947953 Ash et al. Sep 1999 A
5957879 Roberts et al. Sep 1999 A
5957893 Luther et al. Sep 1999 A
5957912 Heitzmann Sep 1999 A
5961486 Twardowski et al. Oct 1999 A
5964796 Imran Oct 1999 A
5976103 Martin Nov 1999 A
5976120 Chow et al. Nov 1999 A
5980551 Summers et al. Nov 1999 A
5984908 Davis et al. Nov 1999 A
5989206 Prosl et al. Nov 1999 A
5989213 Maginot Nov 1999 A
6001079 Pourchez Dec 1999 A
6033382 Basta Mar 2000 A
6036654 Quinn et al. Mar 2000 A
6059771 Balbierz et al. May 2000 A
6074374 Fulton Jun 2000 A
6086555 Eliasen et al. Jul 2000 A
6090096 St. Goar et al. Jul 2000 A
6099513 Spehalski Aug 2000 A
6103778 Hyon et al. Aug 2000 A
6106540 White et al. Aug 2000 A
6113572 Gailey et al. Sep 2000 A
6117117 Mauch Sep 2000 A
6120494 Jonkman Sep 2000 A
6126631 Loggie Oct 2000 A
6146354 Beil Nov 2000 A
6146373 Cragg et al. Nov 2000 A
6152909 Bagaoisan et al. Nov 2000 A
6156016 Maginot Dec 2000 A
6161547 Barbut Dec 2000 A
6178356 Chastain et al. Jan 2001 B1
6180059 Divino, Jr. et al. Jan 2001 B1
6190349 Ash et al. Feb 2001 B1
6190371 Maginot et al. Feb 2001 B1
6193685 Goodin Feb 2001 B1
6196996 Teirstein Mar 2001 B1
6206849 Martin et al. Mar 2001 B1
6210365 Afzal Apr 2001 B1
6210380 Mauch Apr 2001 B1
6217527 Selmon et al. Apr 2001 B1
6224622 Kotzev May 2001 B1
6238406 Ellis et al. May 2001 B1
6264627 Liska et al. Jul 2001 B1
6273879 Keith et al. Aug 2001 B1
6280413 Clark et al. Aug 2001 B1
6280423 Davey et al. Aug 2001 B1
6287326 Pecor Sep 2001 B1
6293927 McGuckin, Jr. Sep 2001 B1
6293958 Berry et al. Sep 2001 B1
6296631 Chow Oct 2001 B2
6299631 Shalaby Oct 2001 B1
6322551 Brugger Nov 2001 B1
6328730 Harkrider, Jr. Dec 2001 B1
6342120 Basta Jan 2002 B1
6361529 Goodin et al. Mar 2002 B1
6383172 Barbut May 2002 B1
6394141 Wages et al. May 2002 B2
6394142 Woelfel et al. May 2002 B1
6409700 Siegel, Jr. et al. Jun 2002 B1
6413228 Hung et al. Jul 2002 B1
6428513 Abrahamson Aug 2002 B1
6443922 Roberts et al. Sep 2002 B1
6450988 Bradshaw Sep 2002 B1
6453185 O'Keefe Sep 2002 B1
6454997 Divino, Jr. et al. Sep 2002 B1
6463335 Munch et al. Oct 2002 B1
6475207 Maginot et al. Nov 2002 B1
6475209 Larson et al. Nov 2002 B1
6478789 Spehalski et al. Nov 2002 B1
6482169 Kuhle Nov 2002 B1
6533763 Schneiter Mar 2003 B1
6565594 Herweck et al. May 2003 B1
6576001 Werneth et al. Jun 2003 B2
6582459 Lau et al. Jun 2003 B1
6585705 Maginot et al. Jul 2003 B1
6592565 Twardowski Jul 2003 B2
6595966 Davey et al. Jul 2003 B2
6620118 Prosl et al. Sep 2003 B1
6638242 Wilson et al. Oct 2003 B2
6659134 Navis Dec 2003 B2
6682498 Ross Jan 2004 B2
6682519 Schon Jan 2004 B1
6695832 Schon et al. Feb 2004 B2
6702776 Quinn Mar 2004 B2
6712797 Southern, Jr. Mar 2004 B1
6712798 Constantz Mar 2004 B2
6719717 Johnson et al. Apr 2004 B1
6719749 Schweikert et al. Apr 2004 B1
6723084 Maginot et al. Apr 2004 B1
6723114 Shalaby Apr 2004 B2
6730299 Tayot et al. May 2004 B1
6752827 Ross et al. Jun 2004 B2
6755851 Noda et al. Jun 2004 B2
6758836 Zawacki Jul 2004 B2
6786664 Claramunt et al. Sep 2004 B2
6786884 DeCant, Jr. et al. Sep 2004 B1
6796991 Nardeo Sep 2004 B2
6797107 Kotzey Sep 2004 B1
6808510 DiFiore Oct 2004 B1
6814718 McGuckin, Jr. et al. Nov 2004 B2
6819951 Patel et al. Nov 2004 B2
6821287 Jang Nov 2004 B1
6824554 Jang Nov 2004 B1
6835452 Hamerski Dec 2004 B1
6837864 Bertolero et al. Jan 2005 B1
6852079 Miyano et al. Feb 2005 B2
6852097 Fulton, III Feb 2005 B1
6858019 McGuckin, Jr. et al. Feb 2005 B2
6872198 Wilson et al. Mar 2005 B1
6878143 Andersen Apr 2005 B2
6881211 Schweikert et al. Apr 2005 B2
6911014 Wentling et al. Jun 2005 B2
6913601 St. Goar et al. Jul 2005 B2
6916313 Cunningham Jul 2005 B2
6921396 Wilson et al. Jul 2005 B1
6921411 Yock Jul 2005 B2
6934142 Grosse et al. Aug 2005 B2
6966886 Appling Nov 2005 B2
6969381 Voorhees Nov 2005 B2
6991625 Gately et al. Jan 2006 B1
D515211 Chesnin Feb 2006 S
6997894 Caresio Feb 2006 B2
7008395 Loggie Mar 2006 B1
7011645 McGuckin, Jr. et al. Mar 2006 B2
7018384 Skakoon Mar 2006 B2
7029467 Currier et al. Apr 2006 B2
7066914 Andersen Jun 2006 B2
7066925 Gately et al. Jun 2006 B2
7074213 McGuckin, Jr. et al. Jul 2006 B2
7077829 McGuckin, Jr. et al. Jul 2006 B2
7087053 Vanney Aug 2006 B2
7090654 Lotito et al. Aug 2006 B2
7108674 Quinn Sep 2006 B2
D530420 Chesnin Oct 2006 S
7128734 Wilson et al. Oct 2006 B1
7130700 Gardeski et al. Oct 2006 B2
7141035 Haggstrom Nov 2006 B2
RE39451 Kuhle Dec 2006 E
7182746 Haarala et al. Feb 2007 B2
7300430 Wilson et al. Nov 2007 B2
7322953 Redinger Jan 2008 B2
7347852 Hobbs et al. Mar 2008 B2
7381204 Wilson et al. Jun 2008 B2
7393339 Zawacki et al. Jul 2008 B2
7422571 Schweikert et al. Sep 2008 B2
7465286 Patterson et al. Dec 2008 B2
7485107 DiFiore et al. Feb 2009 B2
7569029 Clark Aug 2009 B2
7575563 Appling Aug 2009 B2
7798999 Bailey et al. Sep 2010 B2
7972465 Patterson et al. Jul 2011 B2
8021321 Zawacki Sep 2011 B2
8066660 Gregersen Nov 2011 B2
8092415 Moehle Jan 2012 B2
8100863 Moehle et al. Jan 2012 B2
8152951 Zawacki et al. Apr 2012 B2
8206371 Nimkar et al. Jun 2012 B2
8292841 Gregersen Oct 2012 B2
8500939 Nimkar et al. Aug 2013 B2
8540661 Gregersen Sep 2013 B2
8696614 Gregersen et al. Apr 2014 B2
8808227 Zawacki et al. Aug 2014 B2
8894601 Moehle et al. Nov 2014 B2
20010041857 Sansoucy Nov 2001 A1
20010041873 Dopper et al. Nov 2001 A1
20020013569 Sterman et al. Jan 2002 A1
20020026156 Quinn Feb 2002 A1
20020086047 Mueller et al. Jul 2002 A1
20020087108 Maginot et al. Jul 2002 A1
20020087145 Ehwald et al. Jul 2002 A1
20020091362 Maginot et al. Jul 2002 A1
20020091430 Dobak et al. Jul 2002 A1
20020099326 Wilson et al. Jul 2002 A1
20020099327 Wilson et al. Jul 2002 A1
20020107506 McGuckin et al. Aug 2002 A1
20020138031 Ross Sep 2002 A1
20020169490 Noda et al. Nov 2002 A1
20020177904 Huxel et al. Nov 2002 A1
20030023198 Twardowski Jan 2003 A1
20030028140 Greff Feb 2003 A1
20030088213 Schweikert et al. May 2003 A1
20030093027 McGuckin et al. May 2003 A1
20030097091 Hobbs et al. May 2003 A1
20030144623 Heath et al. Jul 2003 A1
20030149395 Zawacki Aug 2003 A1
20030153898 Schon et al. Aug 2003 A1
20030187411 Constantz Oct 2003 A1
20030204179 Davey et al. Oct 2003 A1
20040039350 McKittrick Feb 2004 A1
20040054321 Schon et al. Mar 2004 A1
20040059314 Schon et al. Mar 2004 A1
20040064086 Gottlieb et al. Apr 2004 A1
20040065333 Wilson et al. Apr 2004 A1
20040075198 Schweikert et al. Apr 2004 A1
20040087892 Cunningham May 2004 A1
20040092863 Raulerson et al. May 2004 A1
20040097863 Appling May 2004 A1
20040097903 Raulerson May 2004 A1
20040122418 Voorhees Jun 2004 A1
20040147903 Latini Jul 2004 A1
20040167463 Zawacki et al. Aug 2004 A1
20040171997 Wilson et al. Sep 2004 A1
20040172003 Wilson et al. Sep 2004 A1
20040176739 Stephens et al. Sep 2004 A1
20040193102 Haggstrom Sep 2004 A1
20040210180 Altman Oct 2004 A1
20040210187 Zawacki Oct 2004 A1
20040210237 Ross et al. Oct 2004 A1
20040220550 Schryver Nov 2004 A1
20040230204 Wortley et al. Nov 2004 A1
20040243095 Nimkar et al. Dec 2004 A1
20040249337 DiFiore Dec 2004 A1
20050003322 Logan et al. Jan 2005 A1
20050004504 Frye et al. Jan 2005 A1
20050013341 Baghai Jan 2005 A1
20050025641 Shibata et al. Feb 2005 A1
20050027282 Schweikert et al. Feb 2005 A1
20050027289 Castellano et al. Feb 2005 A1
20050033222 Haggstrom et al. Feb 2005 A1
20050054989 McGuckin et al. Mar 2005 A1
20050055012 Trerotola Mar 2005 A1
20050059925 Maginot et al. Mar 2005 A1
20050070842 Lotito et al. Mar 2005 A1
20050080398 Markel et al. Apr 2005 A1
20050085765 Voorhees Apr 2005 A1
20050096585 Schon et al. May 2005 A1
20050113904 Shank et al. May 2005 A1
20050131341 McGuckin et al. Jun 2005 A1
20050171469 Cunningham Aug 2005 A1
20050187535 Wilson et al. Aug 2005 A1
20050228339 Clark Oct 2005 A1
20050245900 Ash Nov 2005 A1
20050256461 DiFiore et al. Nov 2005 A1
20050261663 Patterson et al. Nov 2005 A1
20050267400 Haarala et al. Dec 2005 A1
20050277862 Anand Dec 2005 A1
20050288623 Hjalmarsson Dec 2005 A1
20050288706 Widomski et al. Dec 2005 A1
20060004316 Difiore et al. Jan 2006 A1
20060004325 Hamatake et al. Jan 2006 A1
20060009783 Rome et al. Jan 2006 A1
20060015072 Raulerson Jan 2006 A1
20060015130 Voorhees et al. Jan 2006 A1
20060030827 Raulerson et al. Feb 2006 A1
20060047267 Gately et al. Mar 2006 A1
20060047268 Stephens Mar 2006 A1
20060058775 Stevens et al. Mar 2006 A1
20060064072 Gately et al. Mar 2006 A1
20060095062 Stephens May 2006 A1
20060100572 DiMatteo et al. May 2006 A1
20060161100 Hamboly Jul 2006 A1
20060184142 Schon et al. Aug 2006 A1
20060189922 Amarasinghe et al. Aug 2006 A1
20060200111 Moehle et al. Sep 2006 A1
20060206094 Chesnin et al. Sep 2006 A1
20060251612 Kotzev et al. Nov 2006 A1
20060253063 Schweikert Nov 2006 A1
20060271012 Canaud et al. Nov 2006 A1
20070005003 Patterson et al. Jan 2007 A1
20070019181 Sinclair et al. Jan 2007 A1
20070066964 Atkins Mar 2007 A1
20070078478 Atkins et al. Apr 2007 A1
20070106206 Appling May 2007 A1
20070129704 O'Mahony et al. Jun 2007 A1
20070167925 Jacqmein Jul 2007 A1
20070225661 Ash et al. Sep 2007 A1
20070225682 Ash et al. Sep 2007 A1
20070282274 Chesnin Dec 2007 A1
20080021417 Zawacki et al. Jan 2008 A1
20080039774 Zawacki et al. Feb 2008 A1
20080082079 Braga et al. Apr 2008 A1
20080082080 Braga Apr 2008 A1
20080097409 Stephens Apr 2008 A1
20080214980 Anand Sep 2008 A1
20080214992 Haarala et al. Sep 2008 A1
20090112153 Gregersen et al. Apr 2009 A1
20090118661 Moehle et al. May 2009 A1
20090118701 Nimkar et al. May 2009 A1
20090118707 Schweikert et al. May 2009 A1
20090192435 Gregersen Jul 2009 A1
20090204052 Nimkar et al. Aug 2009 A1
20090204079 Nimkar et al. Aug 2009 A1
20090205189 Nimkar et al. Aug 2009 A1
20090209940 Nimkar et al. Aug 2009 A1
20100331780 Bellisario et al. Dec 2010 A1
20110020418 Bosley et al. Jan 2011 A1
20120059304 Gregersen et al. Mar 2012 A1
20120089070 Moehle et al. Apr 2012 A1
20120203206 Nimkar et al. Aug 2012 A1
20130079752 Gregersen Mar 2013 A1
20130253445 Nimkar et al. Sep 2013 A1
20140025042 Gregersen Jan 2014 A1
20140088510 Nimkar et al. Mar 2014 A1
20140228742 Gregersen et al. Aug 2014 A1
Foreign Referenced Citations (58)
Number Date Country
834211 Feb 1976 BE
1150122 Jul 1983 CA
2474351 Aug 2003 CA
2788836 Jun 2006 CN
101918067 Dec 2010 CN
103170050 Jun 2013 CN
101918066 Jul 2013 CN
8815869 Mar 1989 DE
9108132 Jun 1991 DE
102005051211 May 2007 DE
0030854 Jun 1981 EP
0132344 Jan 1985 EP
0301854 Feb 1989 EP
0332366 Sep 1989 EP
0332366 Sep 1989 EP
0386408 Sep 1990 EP
0453234 Oct 1991 EP
0476796 Mar 1992 EP
0495263 Jul 1992 EP
0650740 May 1995 EP
0711574 May 1996 EP
1471966 Nov 2004 EP
1599247 Nov 2005 EP
1503469 Mar 1978 GB
56-136569 Oct 1981 JP
8-510935 Nov 1996 JP
2001137350 May 2001 JP
2008500081 Jan 2008 JP
4827377 Nov 2011 JP
249060 Sep 2007 MX
45923 Nov 2004 RU
459237 Feb 1975 SU
9108132 Jun 1991 WO
WO-9316741 Sep 1993 WO
WO-9316752 Sep 1993 WO
9709086 Mar 1997 WO
9717102 May 1997 WO
WO-9722374 Jun 1997 WO
9737699 Oct 1997 WO
9904844 Feb 1999 WO
0023137 Apr 2000 WO
02058776 Aug 2002 WO
02083223 Oct 2002 WO
03030960 Apr 2003 WO
03033049 Apr 2003 WO
03066148 Aug 2003 WO
2004075962 Sep 2004 WO
2004096334 Nov 2004 WO
2004112876 Dec 2004 WO
WO-2005018712 Mar 2005 WO
WO-2005023336 Mar 2005 WO
2005077449 Aug 2005 WO
2005084741 Sep 2005 WO
2005118039 Dec 2005 WO
2006034887 Apr 2006 WO
2009051967 Apr 2009 WO
2009055332 Apr 2009 WO
2009059220 May 2009 WO
Non-Patent Literature Citations (209)
Entry
Xavier, Mário Sérgio Viana and Leite, Vilnei Mattioli. The effect of 2-butyl-cyanoacrylate adhesive in osteotomies and bone grafts in rabbits: macroscopic and radiographic characteristics. Rev. bras. ortop. [online]. 2012, vol. 47, n.5, pp. 638-645. ISSN 0102-3616. http://www.scielo.br/pdf/rbort/v47n5/en—16.pdf.
Biomaterials for Clinical Applications,Sujata K. Bhatia, Oct. 14, 2010, pp. 225-229: http://books.google.com/books?id=bXtaX468LRYC&pg=PA227&lpg=PA227&dq=cyanoacrylate+adhesive+degrades&source=bl&ots=kBoiUpJL6Y&sig=NdEpihbY—L04qcaYo4g1MuMi4qo&hl=en&sa=X&ei=YEoZU8r3OuiX0AHHg4BY&ved=0CFEQ6AEwBA#v=onepage&q=cyanoacrylate%20adhesive%20degrades&f=false.
Arrow Cannon II Plus brochure (2006).
Bander, et al., Central Venous Angioaccess for Hemodialysis and Its Complications, Seminars in Dialysis, 1992, vol. 5, No. 2, pp. 121-128.
Baranowski, L., Central Venous Access Devises, Journal of Intravenous Nursing, 1993, vol. 16, No. 3, pp. 167-194.
Believed to be an unpublished sketch of a conception by Dr. John Frusha; date of sketch believed to be Jun. 24, 1997.
Berkoben, et al., Maintenance of Permanent Hemodialysis Vascular Access Patency, ANNA Journal, 1995, vol. 22, No. 1, pp. 17-24.
Bolz, et al., Catheter Malfunction and Thrombus Formation on Double-Lumen Hemodialysis Catheters: An Intravascular Ultrasonographic Study, American Journal of Kidney Diseases, 1995, vol. 25, No. 4, pp. 597-602.
Bour, et al., Experience With the Double Lumen Silastic® Catheter for Hemoaccess Surgery, Gynecology & Obstetrics, 1990, vol. 171, pp. 33-39.
Campbell, et al., Radiological Insertion of Long-term Venous Access Devises, Seminars in Interventional Radiology, 1994, vol. 11, No. 4. pp. 366-375.
Canaud, B. et al., “Permanent Twin Catheter: A Vascular Access Option of Choice for Haemodialysis in Elderly Patients,” 13(7):82-88 (1998).
Claim Construction Order of Federal District Court dated May 9, 2005 in Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc. litigation (S.D. N.Y. 03 Civ. 0972).
Claim Construction Order of Federal District Court dated Oct. 31, 2006 in Arrow Int'l. Inc. and Arrow Int'l. Investment Corp. v. Spire Biomedical, Inc. litigation, (D. Mass. Civil Action No. 06-CV-11564).
Decision of Federal District Court dated Jul. 7, 2009 granting Summary Judgment of Invalidity in Arrow Int'l. Inc. and Arrow Int'l. Investment Corp. v. Spire Biomedical, Inc. litigation, (D. Mass. Civil Action No. 06-CV-11564).
Dialysis Vascular Access, Technological Innovations Improving Flow(AngioDynamics Inc.) brochure, 4 pages.
Donaldson, et al., Peripherally Inserted Central Venous Catheters: US-guided Vascular Access in Pediatric Patients1, Radiology, 1995, vol. 197, pp. 542-544.
Dunea, et al., A Survey of Permanent Double Lumen Catheters in Hemodialysis Patients, ASAIO Transac. 1991:37:M276-7.
Dupont et al., “Long-Term Development of Permcath Quinton Catheter” [French] Néphrologie 15: 105-10 (1994).
Gallichio, et al., Placement of a Double Lumen Silastic Catheter for Hemodialysis Access Through The Cephalic Vein, Journal of the American College of Surgeons, 1994, vol. 179, pp. 171-172.
Gravenstein, et al., In Vitro Evaluation of Relative Perforating Potential of Central Venous Catheters: Comparison of Materials, Selected Models, Number of Lumens, and Angles of Incidence to Simulated Membrane, Journal of Clinical Monitoring, 1991, vol. 7, pp. 1-6.
Haindl, H., Technical complications for port-catheter systems, Reg. Cancer Treat, 1989, 2:238-242.
Haire, et at., Thrombotic Complications of Subclavian Apheresis catheters in Cancer Patients: Prevention With Heparin Infusion, Journal of Clinical Apheresis, 1990, vol. 5, pp. 188-191.
Hull, et al., The Groshong Catheter: Initial Experience and Early Results of Imaging-guided Placement1, Radiology, 1992, vol. 185, pp. 803-807.
Ignotus, et al., Review of Radiological Insertion of Indwelling Central Venous Catheters, minimally invasive Therapy, 1992, 1:373-388.
Instructions for Use (Copyright Dated 1990) for Polycath Polyurethance Central Venous Catheter; believed to have been packaged with product believed to have been sold in the United States before Jan. 2000 and related marketing materials.
Instructions for Use (Copyright Dated 1992) for FloLock Single Lumen Bi-directional Valved Catheter; believed to have been packaged with product believed to have been sold in the United States before Jan. 2000.
Instructions for Use (not dated) for Infuse-a-Cath Polyurethance Central Venous Catheter; believed to have been packaged with product believed to have been sold in the United States before Jan. 2000.
Instructions for Use for Diatek Cannon Catheter Product First Sold in the United States Sep. 2001.
Jones, et al., Efficacy of the Supraclavicular Route for Temporary Hemodialysis Access, Southern Medical Journal, 1992, vol. 85, No. 7, pp. 725-726.
Kaupke, et al., Perforation of the Superior Vena Cava by a Subclavin Hemodialysis Catheter: early detection by angiography, The International Journal of Artificial Organs, 1992, vol. 15, No. 11, pp. 666-668.
Kelber, et al., Factors Affecting Delivery of High-Efficiency Dialysis Using Temporary Vascular Access, American Journal of Kidney Diseases, 1993, vol. 22, No. 1, pp. 24-29.
Lumsden, et al., Hemodialysis Access in the Pediatric Patient Population, The American Journal of Surgery, 1994, vol. 168, pp. 197-201.
Lund, “Percutaneous Translumber Inferior Vena Cava Cannulation and other Alternative Vascular Access Techniques” in Venous Interventional Radiology with Clinical Perspectives, Savader et al, eds, pp. 251-261 (date unknown).
Lund, et al., Percutaneous Translumber Inferior Vena Cava Cannulation for Hemodialysis, American Journal of Kidney Diseases, 1995, vol. 25, No. 5, pp. 732-737.
Maki, D., Pathogenesis, Prevention, and Management of Infections Due to Intravascular Devices Used for Infusion Therapy, in Infections Associated with Indwelling Medical Devices, Bisno et al, eds, American Society for Microbiology, 1989, pp. 161-177.
Mauro, et al., Radiologic Placement of Long-term Central Venous Catheters: A Review, JVIR, 1993, vol. 4, No. 1, pp. 127-137.
McGee, et al., Accurate placement of central venous catheters: A prospective, randomized, multicenter trial, Critical Care Medicine, 1993, vol. 21, No. 8, pp. 1118-1123.
Medcomp, “For Access via the Internal Jugular Vein . . . The Medcomp TESIO Catheter is the Solution: The Short and Long Term Solution to Subclavian Venin Stenosis and Difficult Access Problems”—Brochure, 4 pp.
Moss, et al., Use of a Silicone Catheter With a Dacron Cuff for Dialysis Short-Term Vascular Access, American Journal of Kidney Diseases, 1988, vol. XII, No. 6, pp. 492-498.
Northsea, C., Using Urokinase to Restore Patency in Double Lumen Catheters, ANNA Journal 1994, vol. 21, No. 5, pp. 261-273.
OriGen, “OriGen Biomedical Dual Lumen Catheter,” http://origen.net/catheter.html, downloaded May 13, 2009, 4 pages.
Parsa, et al., Establishment of Intravenous Lines for Long-term Intravenous Therapy and Monitoring, Surgical Clinics of N. Am. 1985, vol. 65, No. 4, pp. 835-865.
Parsa, et al., Vascular Access Techniques, Monitoring, pp. 122-145 (date unknown).
Pasquale, et al., Groshong® versus Hickman® Catheters, Surgery, Gynecology & Obstetrics, 1992, vol. 174, pp. 408-410.
Passaro, et al., Long-term Silastic Catheters and Chest Pain, Journal of Parenteral andEnteral Nutrition, 1994, vol. 18, Bo. 3, pp. 240-242.
Paulsen, et al., Use of Tissue Plasminogen Activator for Reopening of Clotted Dialysis Catheters, Nephron, 1993, vol. 64, pp. 468-470.
Picture of device believed to be partial sample of a product believed to have been sold in the United States with the Polycath and/or Infuse-a-Cath Instructions for Use, 1 page.
QUINTON® Catheter Products (1993).
Raaf, et al., Open Insertion of Right Atrial Catheters Through the Jugular Veins, surgery, Gynecology & Obstetrics, 1993, vol. 177, pp. 295-298.
Schwab, et al., Prospective Evaluation of a Dacron Cuffed Hemodialysis Catheter for Prolonged Use, American Journal of Kidney Diseases, 1998, vol. XI, No. 2, pp. 166-169.
Schwab, et al., Vascular Access: Case Oriented Discussions of Selected Critical Issues: Hemodialysis Catheters for Permanent Use (date unknown).
Shaffer D., lessons from Vascular Access Procedures for Hemodialysis, Surgical Oncology Clinics of North America, 1995, vol. 4, No. 3, pp. 537-549.
Shaffer, D., Catheter-Related Sepsis Complication Long-Term Tunnelled Central Venous Dialysis Catheters: Management by Guidewire Exchange, American Journal of Kidney Disease, 1995, vol. 25, No. 4. pp. 593-596.
Sioshansi, P., New Processes for Surface Treatment of Catheters, Artificial Organs, 1994, 18(4):266-271.
Swartz, et al., Successful Use of Cuffed Central venous Hemodialysis Catheters Inserted Percutaneously, J. Am. Soc. Nephrol., 1994, 4:1719-1725.
Tesio, et al., Double Catherization of the Internal Jugular Vein for Hemodialysis: Indications, Techniques, and Clinical Results, Artificial Organs, 1994, vol. 18, No. 4, pp. 301-304.
Treiman, et al., Chronic Venous Access in Patients with Cancer, Cancer, 1993, vol. 72, No. 3, pp. 760-765.
Twadorski, et al., “Blood Recirculation in Intravenous Catheters for Hemodialysis” J. am. Soc. Nephrol. 3:1978-81 (1993).
Uldall, P. Subclavian Cannulation Is No longer Necessary or justified in Patients with End-Stage Renal failure, Seminar in Dialysis, 1994, vol. 7, No. 3, pp. 161-164.
Wechsler, et al., Thrombosis and Infection Caused by Thoracic Venous Catheters: Pathogenesis and Imagings Findings, AJR, 1993; 160:467-471.
Weitzel, et al., Successful use if Indwelling Cuffed Femoral Vein Catheters in Ambulatory Hemodialysis Patients, America Journal of Kidney diseases, 1993, vol. 22, No. 3, pp. 426-429.
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW Memorandum of Law in Support of Defendant's Motion for Summary Judgement on Invalidity [Redacted Pursuant to Jun. 10, 2008 Order on Motion to Seal].
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist. Ct Dist. MA CA No. 06-CV-11564-DPW, Plaintiff's Memorandum in Opposition to Defendant's Motion for Summary Judgement on Non-Infringement (Jul. 17, 2008).
Arrow International, Inc. et al. v. Spire Biomedical, Inc., U.S. Dist. Ct. Dist. MA CA No. 06-CV-11564-DPW, Defendant's Omnibus Statement of Material Facts in Support of its Motions for Summary Judgment [Redacted Pursuant to Jun. 10, 2008 Order on Motion to Seal].
Bard Access Systems Hickman®, Leonard®, and Broviac® Central Venous Catheters (Long Term), Instructions for Use, 31 pages, 1999.
Bard Access Systems Hickman®, Leonard®, and Broviac® Central Venous Catheters, Nursing Procedural Manual, 52 pages, Jun. 1994.
Bard Davol® Hickman® Round Dual Lumen Catheters for Central Venous Access Informational Brochure, 2 pages, 1994.
Bard Hickman® Catheters Informational Brochure, 3 pages, 1994.
Camp, “Care of the Groshong Catheter”, Oncol Nurs Forum, vol. 15, No. 6, 1988.
Delmore et al., “Experience with the Groshong Long-Term Central Venous Catheter”, Gynecologic Oncology 34, 216-218 (1989).
DiFiore, “Central Venous Dialysis Catheter Evaluatio in Swine”, Journal of Vascular Access Devices, Fall 2000.
Dupont et al, “Long-Term Development of Permcath Quinton Catheter” [French] Néphrologie 15: 105-10 (1994) (with English summary).
EP 04712925.9 filed Feb. 19, 2004 Office Action dated Nov. 7, 2008.
EP 08839196.6 filed Oct. 2, 2008 Search Opinion dated Jul. 12, 2011.
EP 08839196.6 filed Oct. 2, 2008 Search Report dated Jul. 12, 2011.
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Decision of Refusal mailed Dec. 24, 2009.
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed May 28, 2009.
JP App. No. 2003-565569 filed Feb. 7, 2003, Translated Official Action mailed Nov. 7, 2008.
Malviya et al., “Vascular Access in Gynecological Cancer Using the Groshong Right Atrial Catheter”, Gynecological Oncology 33, 313-316 (1989).
Medcomp® Brochure , “Ash Split Cath™ XL”, Dec. 2001, PN 2291.
Medcomp® Brochure , “Ash Split Cath™”, Guidewire Weave Insertion Technique, Jan. 2002, PN 2296.
Medcomp® Brochure , “Ash Split Cath™”, Jul. 2001, PN 2114.
Medcomp® Brochure , “Ash Split Cath™”, Nov. 1997, PN 2050.
Medcomp® Brochure , “Ash Split Cath® II ”, Aug. 2002, PN 2334.
Medcomp® Brochure , “Magna™ High Flow Catheter”, Mar. 2002, PN 2321.
Moss et al, Use of Silicone Dual-Lumen Catheter with a Dacron Cuff as a Long Term Vascular Access for Hemodialysis Patients, Amer J Kidney Diseases, vol. XVI, No. 3, pp. 211-215, Sep. 1990.
Myers, R.D. et al, New Double-lumen Polyethylene Cannula for Push-pull Perfusion of Brain Tissue in Vivo, Journal of Neuroscience Methods, pp. 205-218, vol. 12, 1985.
Patel et al., “Sheathless Technique of Ash Split-Cath Insertion”, 12 JVIR 376-78 (Mar. 2001).
PCT/US2003/003751 filed Feb. 7, 2003 Preliminary Examination Report dated May 5, 2004.
PCT/US2003/003751 filed Feb. 7, 2003 Search Report dated Jul. 3, 2003.
PCT/US2004/005102 filed Feb. 19, 2004 Preliminary Report Patenability dated Aug. 29, 2005.
PCT/US2004/005102 filed Feb. 19, 2004 Search Report dated Dec. 27, 2004.
PCT/US2004/005102 filed Feb. 19, 2004 Written Opinion dated Aug. 21, 2005.
PCT/US2008/078551 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010.
PCT/US2008/078551 filed Oct. 2, 2008 Search Report dated Mar. 13, 2009.
PCT/US2008/078551 filed Oct. 2, 2008 Written Opinion dated Mar. 13, 2009.
PCT/US2008/078560 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010.
PCT/US2008/078560 filed Oct. 2, 2008 Search Report dated Mar. 16, 2009.
PCT/US2008/078560 filed Oct. 2, 2008 Written Opinion dated Mar. 16, 2009.
PCT/US2008/078566 filed Oct. 2, 2008 International Preliminary Report on Patentability dated Apr. 20, 2010.
PCT/US2008/078566 filed Oct. 2, 2008 Search Report dated Mar. 19, 2009.
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Jun. 16, 2009.
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Nov. 13, 2008.
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Nov. 23, 2009.
PCT/US2008/078566 filed Oct. 2, 2008 Written Opinion dated Mar. 19, 2009.
PCT/US2008/078571 filed Oct. 2, 2008 Preliminary Report on Patentability dated Aug. 26, 2010.
PCT/US2008/078571 filed Oct. 2, 2008 Search Report dated Mar. 20, 2009.
PCT/US2008/078571 filed Oct. 2, 2008 Written Opinion dated Mar. 20, 2009.
PCT/US2008/080463 filed Oct. 20, 2008 Preliminary Report on Patentability dated Apr. 27, 2010.
PCT/US2008/080463 filed Oct. 20, 2008 Search Report dated Mar. 16, 2009.
PCT/US2008/080463 filed Oct. 20, 2008 Written Opinion dated Apr. 16, 2009.
PCT/US2008/082106 International Preliminary Report on Patentability dated May 4, 2010.
PCT/US2008/082106 Search Report dated Jan. 12, 2009.
PCT/US2008/082106 Written Opinion dated Jan. 12, 2009.
Raaf Dual Lumen Right Atrial Catheters Brochure—Quinton Instrument Co., 6 pages, 1993.
Rawn, et al., The Hemodialysis Access, Chapter 9, pp. 9.1-9.11.
Tal, Michael G, Comparison of Recirculation Percentage of the Palindrome Catheter and Standard Hemodialysis Catheters in a Swine Model, J Vasc Interv Radio!, pp. 1237-1240, vol. 16, No. 9, 2005.
The Groshong™ Peripherally Inserted Central Venous Catheter Brochure—Cath-tech®, 4 pages, 1988.
Transcript of Videotaped Deposition of Gregory Haas (Excerpt), Sep. 23, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.).
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 1, Oct. 16, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.).
Transcript of Videotaped Deposition of Thierry Pourchez, vol. 2, Oct. 17, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. and Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.).
Twardowski et al. “Side Holes at the Tip of Chronic Hemodialysis Catehters are Harmful,” The Journal of Vascular Access 2001; 2:8-16.
Twardowski, et al., Side Holes at the Tip of Chronic Hemodialysis Catheters are Harmful, The Journal of Vascular Access 2001; 2: 8 16.
TYCO Healthcare, Mahurkar Dual Lumen Catheters, Informational Brochure, 2 pages, 2004.
TYCO Healthcare, Mahurkar QPlus High Flow Acute Care Catheter, Informational Brochure, 2 pages, 2004.
TYCO Healthcare, Tal Palindrome™ Dual Lumen Catheters Order Information, Features and Benefits, Frequently Asked Questions, printed from http://www.kendallvasculartherapy.com/VascularTherapy, 6 pages, on Mar. 1, 2007.
U.S. Appl. No. 10/445,731, filed May 27, 2003 Non-Final Office Action dated Apr. 13, 2007.
U.S. Appl. No. 10/445,731, filed May 27, 2003 Non-Final Office Action dated Dec. 12, 2008.
U.S. Appl. No. 10/445,731, filed May 27, 2003 Non-Final Office Action dated May 30, 2008.
U.S. Appl. No. 11/859,106, filed Sep. 21, 2007 Final Office Action dated Sep. 1, 2009.
U.S. Appl. No. 11/859,106, filed Sep. 21, 2007 Non-Final Office Action dated Mar. 30, 2011.
U.S. Appl. No. 11/859,106, filed Sep. 21, 2007 Non-Final Office Action dated Jun. 25, 2008.
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Final Office Action dated Jan. 20, 2011.
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Non-Final Office Action dated Jan. 7, 2010.
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Non-Final Office Action dated Jul. 7, 2010.
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Non-Final Office Action dated May 12, 2009.
U.S. Appl. No. 12/244,514, filed Oct. 2, 2008 Final Office Action dated Jul. 11, 2011.
U.S. Appl. No. 12/244,514, filed Oct. 2, 2008 Non-Final Office Action dated Jan. 19, 2011.
U.S. Appl. No. 12/244,544, filed Oct. 2, 2008 Final Office Action dated Jul. 11, 2011.
U.S. Appl. No. 12/244,544, filed Oct. 2, 2008 Non-Final Office Action dated Dec. 22, 2010.
U.S. Appl. No. 12/244,554, filed Oct. 2, 2008 Final Office Action dated Dec. 27, 2010.
U.S. Appl. No. 12/244,554, filed Oct. 2, 2008 Non-Final Office Action dated Jul. 6, 2010.
U.S. Appl. No. 12/253,870, filed Oct. 17, 2008 Non-Final Office Action dated Jan. 21, 2011.
U.S. Appl. No. 12/253,870, filed Oct. 17, 2008 Notice of Allowance dated Aug. 19, 2011.
U.S. Appl. No. 12/262,820, filed Oct. 31, 2008 Non-Final Office Action dated Feb. 18, 2011.
U.S. Appl. No. 12/263,141, filed Oct. 31, 2008 Advisory Action dated Aug. 17, 2011.
U.S. Appl. No. 12/263,141, filed Oct. 31, 2008 Final Office Action dated May 26, 2011.
U.S. Appl. No. 12/263,141, filed Oct. 31, 2008 Non-Final Office Action dated Jan. 5, 2011.
U.S. Appl. No. 12/414,467, filed Mar. 30, 2009 Non-Final Office Action dated Aug. 11, 2011.
U.S. Appl. No. 10/842,586, filed May 10, 2004 Advisory Action dated Oct. 9, 2008.
U.S. Appl. No. 10/842,586, filed May 10, 2004 Final Office Action dated May 25, 2010.
U.S. Appl. No. 10/842,586, filed May 10, 2004 Final Office Action dated Jul. 29, 2008.
U.S. Appl. No. 10/842,586, filed May 10, 2004 Non-Final Office Action dated Jan. 7, 2008.
CN 200880121182.0 filed Oct. 20, 2008 First Office Action dated May 2, 2012.
CN 200880121183.5 filed Oct. 2, 2008 First Office Action dated Mar. 28, 2012.
CN 200880121183.5 filed Oct. 2, 2008 Second Office Action dated Aug. 17, 2012.
CN 200880123095.9 filed Oct. 20, 2008 First Office Action dated Feb. 13, 2012.
CN 200880123533.1 filed Jun. 30, 2008 First Office Action dated May 28, 2012.
EP 08872340.8 filed Oct. 2, 2008 Extended European Search Report and an Opinion dated Apr. 19, 2012.
JP 2010-532299 filed Apr. 30, 2010 Official Action dated Apr. 23, 2012.
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Final Office Action dated Jan. 19, 2007.
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Final Office Action dated Mar. 7, 2007.
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Non-Final Office Action dated Jul. 17, 2006.
U.S. Appl. No. 10/371,774, filed Feb. 21, 2003 Notice of Allowance dated Jun. 1, 2007.
U.S. Appl. No. 11/859,106, filed Sep. 21, 2007 Non-Final Office Action dated Feb. 5, 2009.
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Examiner's Answer dated Apr. 28, 2010.
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Final Office Action dated Jul. 22, 2009.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jan. 6, 2009.
U.S. Appl. No. 11/874,447 filed Oct. 18, 2007 Non-Final Office Action dated Jul. 9, 2008.
U.S. Appl. No. 12/048,871, filed Mar. 14, 2008 Examiner's Answer dated Feb. 9, 2012.
U.S. Appl. No. 12/244,514, filed Oct. 2, 2008 Final Office Action dated Jun. 19, 2012.
U.S. Appl. No. 12/244,514, filed Oct. 2, 2008 Non-Final Office Action dated Jan. 17, 2012.
U.S. Appl. No. 12/244,559, filed Oct. 2, 2009 Final Office Action dated Jul. 3, 2012.
U.S. Appl. No. 12/244,559, filed Oct. 2, 2009 Non-Final Office Action dated Mar. 14, 2012.
U.S. Appl. No. 12/244,514, filed Oct. 2, 2008 Advisory Action dated Sep. 5, 2012.
U.S. Appl. No. 12/262,820, filed Oct. 31, 2008 Notice of Allowance dated Sep. 28, 2011.
U.S. Appl. No. 12/414,467, filed Mar. 30, 2009 Final Office Action dated Feb. 7, 2012.
U.S. Appl. No. 12/414,467, filed Mar. 30, 2009 Notice of Allowance dated May 31, 2012.
US Patent File History USPN 5,403,291 (Abrahamson).
US Patent File History USPN 5,489,278 (Abrahamson).
US Patent File History USPN 5,685,867 (Twardowski et al.).
CN 200880121183.5 filed Oct. 2, 2008 Third Office Action dated Dec. 11, 2012.
CN 200880123095.9 filed Oct. 20, 2008 Second Office Action dated Dec. 18, 2012.
CN 200880123533.1 filed Jun. 30, 2008 Notice of Grant dated Dec. 24, 2012.
EP 08839196.6 filed Oct. 2, 2008 Examination Report dated Jan. 16, 2013.
JP 2010-532299 filed Apr. 30, 2010 Final Notice of Reason for Rejection dated Feb. 8, 2013.
Septum, Wikipedia, The Free Encyclopedia, hhtp://en.wikipedia.org/wiki/Septum (last visited Dec. 18, 2012) (defining “septum” as “a wall, dividing a cavity or structure into smaller ones”).
Taber's Cyclopedic Medical Dictionary 1662 (16th ed. 1989) (defining “septum” as a “wall dividing two cavities”).
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Decision on Appeal dated Dec. 26, 2012.
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Non-Final Office Action dated Jul. 12, 2013.
U.S. Appl. No. 12/244,559, filed Oct. 2, 2008 Examiners Answer dated Mar. 27, 2013.
U.S. Appl. No. 13/294,941, filed Nov. 11, 2011 Non-Final Office Action dated May 31, 2013.
U.S. Appl. No. 13/445,713, filed Apr. 12, 2012 Advisory Action dated Aug. 8, 2013.
U.S. Appl. No. 13/445,713, filed Apr. 12, 2012 Final Office Action dated May 30, 2013.
U.S. Appl. No. 13/445,713, filed Apr. 12, 2012 Non-Final Office Action dated Jan. 2, 2013.
U.S. Appl. No. 13/445,713, filed Apr. 12, 2012 Notice of Allowance dated Oct. 18, 2013.
U.S. Appl. No. 11/874,447, filed Oct. 18, 2007 Notice of Allowance dated Apr. 18, 2014.
U.S. Appl. No. 13/294,941, filed Nov. 11, 2011 Notice of Allowance dated Nov. 27, 2013.
U.S. Appl. No. 13/329,159, filed Dec. 16, 2011 Non-Final Office Action dated May 16, 2014.
CN 201310073124.8 filed Mar. 7, 2013 First Office Action dated May 5, 2014.
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist Ma Ca No. 06-CV-11564-DPW, Declaration of Dr. Karim Valji (Jul. 17, 2008).
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Kenneth Todd Cassidy (Jul. 16, 2008).
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Declaration of Rebecca R. Eisenberg in Opposition to Defendant's Motion for Partial Summary Judgment of Invalidity (Jun. 8, 2009).
Arrow International, Inc. et al v. Spire Biomedical, Inc., U.S. Dist Ct Dist MA CA No. 06-CV-11564-DPW, Memorandum of Law in Support of Defendant's Motion for Summary Judgment on Invalidity Exhibit A (Jul. 10, 2009).
Declaration of Gregory S. Haas (Plaintiff's Exhibit 88 in Haas Deposition), Mar. 13, 2003, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. And Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.).
Defendant's Exhibits DX78-DX114, Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. And Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.), 2003.
Defendants' Reponses and Objections to Plaintiffs' Second Set of Interrogatories (Excerpt), Thierry Pourchez and Bard Access Systems, Inc. v. Diatek, Inc. And Arrow International, Inc., Civil Action No. 03-CV-0972 (S.D.N.Y.) (Oct. 8, 2003).
Dialysis Vascular Access, SchonXL® Temporary Dialysis (AngioDynamics Inc.) brochure, Nov. 1998.
Kapoian et al. Dialysis as Treatment of End-Stage Renal Disease, Chapter 5: Dialysis Access and Recirculation, © 1999.
Related Publications (1)
Number Date Country
20050277862 A1 Dec 2005 US